Travere Therapeutics
TVTX
#4817
Rank
โ‚น126.98 B
Marketcap
โ‚น1,459
Share price
-1.26%
Change (1 day)
93.62%
Change (1 year)

Revenue for Travere Therapeutics (TVTX)

Revenue in 2024 (TTM): โ‚น16.97 Billion

According to Travere Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น17.27 Billion. In 2023 the company made a revenue of โ‚น12.09 Billion a decrease over the revenue in the year 2022 that were of โ‚น15.44 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Travere Therapeutics from 2011 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น16.97 B40.42%
2023 โ‚น12.09 B-21.7%
2022 โ‚น15.44 B-8.81%
2021 โ‚น16.93 B16.74%
2020 โ‚น14.50 B16%
2019 โ‚น12.50 B8.87%
2018 โ‚น11.48 B16.09%
2017 โ‚น9.89 B8.98%
2016 โ‚น9.07 B36.75%
2015 โ‚น6.63 B271.38%
2014 โ‚น1.78 B
2013 N/A
2012 N/A
2011 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น19.19 M-99.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น60.41 B 249.68%๐Ÿ‡บ๐Ÿ‡ธ USA